Voyageur Pharmaceuticals Ltd. (TSXV:VM)

Voyageur Pharmaceuticals Statistics

Total Valuation

TSXV:VM has a market cap or net worth of CAD 21.43 million. The enterprise value is 21.20 million.

Market Cap	21.43M
Enterprise Value	21.20M

Important Dates

The next estimated earnings date is Tuesday, April 14, 2026.

Earnings Date	Apr 14, 2026
Ex-Dividend Date	n/a

Share Statistics

TSXV:VM has 178.59 million shares outstanding. The number of shares has increased by 20.37% in one year.

Current Share Class	178.59M
Shares Outstanding	178.59M
Shares Change (YoY)	+20.37%
Shares Change (QoQ)	+6.52%
Owned by Insiders (%)	9.07%
Owned by Institutions (%)	n/a
Float	162.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,834.01
PB Ratio	17.11
P/TBV Ratio	17.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.00
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.70

Financial Position

The company has a current ratio of 0.33, with a Debt / Equity ratio of 0.03.

Current Ratio	0.33
Quick Ratio	0.22
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -415.01% and return on invested capital (ROIC) is -201.04%.

Return on Equity (ROE)	-415.01%
Return on Assets (ROA)	-63.41%
Return on Invested Capital (ROIC)	-201.04%
Return on Capital Employed (ROCE)	-223.85%
Weighted Average Cost of Capital (WACC)	6.20%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.00
Inventory Turnover	0.20

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.41% in the last 52 weeks. The beta is 0.36, so TSXV:VM's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	-29.41%
50-Day Moving Average	0.14
200-Day Moving Average	0.17
Relative Strength Index (RSI)	43.62
Average Volume (20 Days)	62,936

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSXV:VM had revenue of CAD 11,685 and -3.53 million in losses. Loss per share was -0.02.

Revenue	11,685
Gross Profit	n/a
Operating Income	-2.89M
Pretax Income	-3.53M
Net Income	-3.53M
EBITDA	-2.89M
EBIT	-2.89M
Loss Per Share	-0.02

Balance Sheet

The company has 270,554 in cash and 40,000 in debt, with a net cash position of 230,554 or 0.00 per share.

Cash & Cash Equivalents	270,554
Total Debt	40,000
Net Cash	230,554
Net Cash Per Share	0.00
Equity (Book Value)	1.25M
Book Value Per Share	0.01
Working Capital	-1.22M

Cash Flow

In the last 12 months, operating cash flow was -2.89 million and capital expenditures -270,020, giving a free cash flow of -3.16 million.

Operating Cash Flow	-2.89M
Capital Expenditures	-270,020
Depreciation & Amortization	1,133
Net Borrowing	n/a
Free Cash Flow	-3.16M
FCF Per Share	-0.02

Margins

Gross Margin	n/a
Operating Margin	-24,758.84%
Pretax Margin	-30,231.56%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSXV:VM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.37%
Shareholder Yield	-20.37%
Earnings Yield	-16.48%
FCF Yield	-14.76%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSXV:VM has an Altman Z-Score of -1.18 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.18
Piotroski F-Score	2